Biotech's Complex Moment: What's Next for Europe?

Biotech is growing more complex as companies race to source Asian assets for newcos in the West and geopolitical tensions challenge globalization, data sharing and cross-border talent exchange.

What's next for European biotech? Can it rise to the complexity of the moment? Can it match the growing competition and walk the fine line of geopolitics?

Celebrating its 25th year, Bio€quity Europe is the destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.

Bio€quity Europe 2025 BrochureDownload the latest event brochure to stay informed and up to date
DOWNLOAD BROCHURE

MEET THE FACULTY

LinkedIn
Arthur Franken
General Partner
Gilde Healthcare
LinkedIn
Anja Koenig, Ph.D.
Global Head
Novartis Venture Fund
LinkedIn
Carole Nuechterlein
Head
Roche Venture Fund
LinkedIn
Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners
LinkedIn
Naveed Siddiqi, M.D.
Senior Partner
Novo Holdings
LinkedIn
Nathalie Ter Wengel, Ph.D.
European Lead Worldwide Business Development
Pfizer
View More Facultyright-arrow

Looking to meet investors? Bio€quity Europe attracts more VCs than any biotech event.Don’t miss your chance — register now before we sell out.
REGISTER NOW

What Will I Learn?

The NewCo Model: Western and Asia leaders discuss the opportunities and challenges, and debate what's in it for Europe.

Pharma BD Roundtable: A panel of pharma BD&L leaders discuss how biotechs can navigate the complexity of the moment and differentiate themselves from the growing competition.

Navigating Policy: A panel of insiders will describe the situation in Washington, focusing on ways to maximize opportunities and minimize risks.

AND MUCH MORE: VIEW THE AGENDA >>

Why Should I Attend?

Debate what is next for the European biotech ecosystem

Meet VCs, CEOs and BD&L leaders in an intimate setting designed for networking and discussion

Discover 100+ emerging biotechs selected for the Presenting Company Track

Schedule partnering meetings with potential partners and investors

Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company

Let BioCentury help you find your next partner with the Presenting Companies Dashboard.

Over 100 biotechs, selected by BioCentury, will present their science on stage at Bio€quity Europe. Visit the Presenting Company Dashboard to learn more about each company, including unpartnered assets you may want to target.

View the Dashboard >>

Apply to Present >>

Discover your next investor at the 25th Bio€quity EuropeAdvanced rates end March 28
REGISTER NOW

Share your Story on Stage

Are you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2025 to increase your visibility and drive partnering requests. Limited space - submit your nominations today.

*⁠The 25th Bio€quity Europe has reached full capacity for in-person presentation slots; however, virtual presentation slots are available.

Apply to Present >>

Deliver Thought Leadership

Share your insights, elevate your brand, position yourself as a peer to biopharma decision-makers and investors.

Learn More >>

Network, partner and debate critical issues facing the biotech industry
REGISTER NOW